Explore the latest news and updates in the field of pancreatic cancer research. Stay informed about the cutting-edge research conducted by Kreftforeningens Nasjonale Ekspertgruppe for Pancreaskreftforskning (KNEP).


The results of a new study by the Pathology work package were presented at the annual meeting of the Norwegian Pathology Society. The study shows that pathology evaluation of the effect of neoadjuvant treatment of pancreatic cancer, is only reliable if tumour regression is extensive, while lesser degrees of treatment effect cannot be identified with certainty. Maia Blomhoff Holm (to the right on the photograph), who presented the study, was awarded the “Research prize 2024 – best free paper”. Read the publication here.


Stina M. Stålberg, MD, PhD student at Dept. of Cancer Genetics, ICR, Oslo University Hospital and USN (work package: “Omics and biomarkers”) presented a poster with results from a research project on protein levels of KRAS in pancreatic cancer at the Nordic Precision Cancer Medicine, Acta Oncologica Conference, Holmenkollen Park Hotel in Oslo, September 17-19, 2023.


Professor Oddmund Nordgård from Stavanger visited the Department of Pathology, Haukeland University hospital on January 10th. He gave a talk about his studies on circulating tumor DNA in pancreatic cancer. The presentation was very well received among the audience of more than 25 pathologists and molecular biologists, and was followed by a vivid discussion. Nordgård also had meetings with two research groups in Bergen to strengthen the collaborations between groups of the KNEP network.